
Deep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform. They aim to program therapies for any gene and any genetic condition by untangling the complexity in RNA biology, identifying novel targets, and evaluating thousands of possibilities to identify the best therapeutic candidates. Their proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth, with their foundation model for RNA Biology, BigRNA, released in 2023 and BigRNA+ currently in development. The company has a diverse team of over 100 members with expertise across AI, genomics, drug development, and related fields, and operates from offices in Toronto, Canada, and Boston, USA.

Deep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform. They aim to program therapies for any gene and any genetic condition by untangling the complexity in RNA biology, identifying novel targets, and evaluating thousands of possibilities to identify the best therapeutic candidates. Their proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth, with their foundation model for RNA Biology, BigRNA, released in 2023 and BigRNA+ currently in development. The company has a diverse team of over 100 members with expertise across AI, genomics, drug development, and related fields, and operates from offices in Toronto, Canada, and Boston, USA.
About Us Deep Genomics is at the forefront of integrating artificial intelligence and complex biology to transform drug discovery. Our proprietary machine learning platform decodes the complexity of RNA biology to identify novel drug targets, mechanisms and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, genetics, chemistry and drug development, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how medicines are created.
Where You Fit In You’ll be joining our Finance team and reporting directly to the Head of Finance, using your skills to make our team efficient, accurate, and forward-thinking.
We are seeking a highly analytical and business-oriented FP&A Manager to lead financial planning, forecasting, and contribute to other areas of the department as needed. This role will serve as a strategic partner to leadership, driving visibility, accountability, and financial rigor across the organization.
The ideal candidate thrives in a fast-paced environment, translates complex financial data into actionable insights, and builds scalable processes.
Key Responsibilities
Qualifications
What We Offer
$110,000 - $125,000 a year
We offer competitive compensation aligned with local market benchmarks. The salary range for this role is $110,000 - $125,000, and reflects Canada-based roles; compensation may differ for U.S.-based candidates.
Deep Genomics encourages applications from all backgrounds who seek the opportunity to build the world's leading AI-driven genetic medicine company.
If you have a disability or special need, accommodation is available on request for candidates taking part in all aspects of the selection process.
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.